What is Hyperparathyroidism

Hyperparathyroidism is a condition characterized by the overactivity of one or more of the four parathyroid glands, leading to an excess of parathyroid hormone (PTH) in the bloodstream. This hormonal imbalance disrupts the body’s ability to regulate calcium levels, which can lead to systemic issues involving bones, kidneys, and the nervous system. Currently, 154 people with Hyperparathyroidism have joined the DiseaseMaps.org community to share their experiences and navigate this condition together.

What is the underlying mechanism of Hyperparathyroidism?

The parathyroid glands, located in the neck near the thyroid, are responsible for maintaining a precise balance of calcium in your body. In individuals with Hyperparathyroidism, these glands produce too much parathyroid hormone, causing the body to pull calcium from the bones into the blood. This results in hypercalcemia (high blood calcium levels), which can affect multiple body systems. The condition typically manifests in three distinct classifications: primary, secondary, and tertiary Hyperparathyroidism. Primary Hyperparathyroidism is the most common form, usually caused by a benign tumor (adenoma) on one of the glands, while secondary and tertiary forms are often responses to chronic kidney disease or vitamin D deficiency.

Who is typically affected by Hyperparathyroidism?

Hyperparathyroidism is most frequently diagnosed in adults over the age of 50, though it can occur at any age. Epidemiological data indicates that the condition is significantly more common in women than in men, with a ratio of approximately 3:1. While the exact prevalence varies by region, primary Hyperparathyroidism is estimated to affect roughly 1 in every 800 to 1,000 people in the general population. Because early symptoms can be subtle—such as fatigue, mild depression, or bone aches—many individuals remain undiagnosed for years until routine blood work reveals elevated calcium levels.

How does Hyperparathyroidism affect the body?

Because calcium is essential for nerve transmission, muscle contraction, and bone strength, the systemic impact of Hyperparathyroidism is widespread. The following systems are most commonly affected:

• Skeletal System: Excessive PTH leads to bone resorption, which can cause osteoporosis, bone pain, and an increased risk of fractures.


• Renal System: High calcium levels in the urine often result in the formation of kidney stones and can impair overall kidney function.


• Digestive System: Patients may experience abdominal pain, nausea, or an increased risk of peptic ulcers.


• Neurological/Psychiatric: Many individuals report "brain fog," memory loss, fatigue, and mood disturbances.

How is this condition different from other endocrine disorders?

It is important to distinguish Hyperparathyroidism from hyperthyroidism. While both involve glands in the neck, they are entirely different organs with different functions. Hyperthyroidism involves the thyroid gland and metabolic rate, whereas Hyperparathyroidism specifically regulates calcium homeostasis. Furthermore, unlike many conditions that cause low bone density due to lack of minerals, Hyperparathyroidism causes bone loss specifically due to the body's over-secretion of hormones that "rob" the bones of their mineral content.

Next steps

• Consult an endocrinologist to request serum calcium and PTH blood tests to confirm a diagnosis.


• Request a DEXA scan to assess your bone density if you have been diagnosed with this condition.


• Connect with the 154 members of the DiseaseMaps.org community to share experiences and coping strategies.


• Maintain adequate hydration to support kidney health while awaiting further clinical evaluation.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the guidance of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Hyperparathyroidism Overview.


• Orphanet: Primary Hyperparathyroidism (ORPHA:399).


• OMIM (Online Mendelian Inheritance in Man): Parathyroid Hormone; PTH.


• The American Association of Endocrine Surgeons (AAES): Patient Education on Parathyroid Disorders.